Wordt geladen...
Thrombopoietin Receptor Levels in Tumor Cell Lines and Primary Tumors
Thrombopoietin (TPO) receptor agonists represent a new approach for the treatment of thrombocytopenia, which may develop as a consequence of immune thrombocytopenia, chemotherapy treatment, chronic hepatitis C infection, or myelodysplastic syndromes. There are concerns that use of certain growth fac...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Hindawi Publishing Corporation
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3026977/ https://ncbi.nlm.nih.gov/pubmed/21318160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2010/135354 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|